Literature DB >> 8458981

Properties and type antigen patterns of group B streptococcal isolates from pigs and nutrias.

I W Wibawan1, C Lämmler, J Smola.   

Abstract

All 59 group B streptococcal cultures isolated from pigs and nutrias reacted with group B-specific antiserum and gave a positive CAMP reaction in the zone of staphylococcal beta-lysin. Most of the cultures were pigmented; all cultures hydrolyzed Na hippurate and utilized salicin, maltose, and saccharose but not esculin, mannitol, or inulin. Fifty-three percent of the group B streptococci from pigs and none of those from nutrias were lactose positive. Serotyping revealed that most of the group B streptococci from pigs were of serotype III and most of those from nutrias were of type Ia/c. Protein c was present as c beta antigen. All group B streptococci were susceptible to penicillin and bacitracin (10 U), and most of the porcine cultures were resistant to tetracycline. According to these results, group B streptococci from pigs and nutrias differ from bovine and human group B streptococci and seem to play no role in cross-infections between animals or between animals and humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458981      PMCID: PMC262868          DOI: 10.1128/jcm.31.3.762-764.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Use of autoclaved extracts of hemolytic streptococci for serological grouping.

Authors:  L A RANTZ; E RANDALL
Journal:  Stanford Med Bull       Date:  1955-05

2.  Streptococcal fish pathogen.

Authors:  J A Robinson; F P Meyer
Journal:  J Bacteriol       Date:  1966-08       Impact factor: 3.490

3.  Bèta-hemolytic streptococci from pigs: bacteriological diagnosis.

Authors:  J Hommez; L A Devriese; F Castryck; C Miry
Journal:  Zentralbl Veterinarmed B       Date:  1991-08

Review 4.  Streptococcal ecovars associated with different animal species: epidemiological significance of serogroups and biotypes.

Authors:  L A Devriese
Journal:  J Appl Bacteriol       Date:  1991-12

Review 5.  Group B streptococcal infection in humans.

Authors:  H W Wilkinson
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

6.  Group B streptococcal sepsis in adults and infants. Contrasts and comparisons.

Authors:  S M Opal; A Cross; M Palmer; R Almazan
Journal:  Arch Intern Med       Date:  1988-03

7.  Pigment production in human and bovine streptococcus agalactiae strains.

Authors:  I Brglez
Journal:  Zentralbl Bakteriol Mikrobiol Hyg B       Date:  1983-09

8.  Phenotypic diversity in the alpha C protein of group B streptococci.

Authors:  L C Madoff; S Hori; J L Michel; C J Baker; D L Kasper
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Neonatal septicaemia.

Authors:  T Vesikari; M Janas; P Grönroos; N Tuppurainen; M Renlund; P Kero; M Koivisto; M Kunnas; K Heinonen; R Nyman
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

10.  Screening of type Ia and Ib Streptococcus agalactiae strains with high sialic acid levels by determination of susceptibility to tetracyclines.

Authors:  Y Nagano; N Nagano; S Takahashi; A Suzuki; Y Okuwaki
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

View more
  3 in total

Review 1.  Molecular epidemiology of group B streptococcal infections.

Authors:  E Tkacikova; I Mikula; A Dmitriev
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

2.  Genetic heterogeneity of the pathogenic potentials of human and bovine group B streptococci.

Authors:  A Dmitriev; E Shakleina; L Tkáciková; I Mikula; A Totolian
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

3.  Prevalence and Characteristics of Streptococcus agalactiae from Freshwater Fish and Pork in Hong Kong Wet Markets.

Authors:  Dulmini Nanayakkara Sapugahawatte; Carmen Li; Priyanga Dharmaratne; Chendi Zhu; Yun Kit Yeoh; Jun Yang; Norman Wai Sing Lo; Kam Tak Wong; Margaret Ip
Journal:  Antibiotics (Basel)       Date:  2022-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.